Skip to content

Aura Biosciences

US · AURA #3544 by market cap Listed 2021
6.87 -0.11 -1.58%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 6.76 -3.15%
After-hours 6.77 -1.46%
8.166.006.872026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on AURA?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +8.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 10.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -3.38%
1M +4.73%
3M -11.58%
6M -8.03%
YTD +26.06%
1Y +28.41%
3Y -17.33%
5Y -69.47%

Key statistics

Price & volume

Prev close
6.98
Open
6.51
Day range
6.51 - 6.98
Avg price
6.87
Volume
791.13K
Turnover
5.43M
Amplitude
6.73%
52-week range
4.73 - 9.54

Valuation

P/E
-3.90
P/E (TTM)
-4.32
P/B
2.49
EPS
-1.76
Net profit
-183.17M
Net assets
287.45M

Share structure

Market cap
714.99M
Float cap
512.86M
Shares out
104.07M
Float shares
74.65M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2021-10-29
52-week range 45% of range
4.73 9.54

27.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+821.32K net over the window

Short interest

Shares short
10.46M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Aura Biosciences (AURA)?

Aura Biosciences last traded at 6.87. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Aura Biosciences's market cap?

About 714.99M.

What is the P/E ratio of Aura Biosciences?

The trailing twelve-month P/E is -4.32. The Valuation tab shows it against the stock's own five-year range.

Does Aura Biosciences pay a dividend?

Aura Biosciences does not currently pay a regular dividend.

Is Aura Biosciences a buy according to analysts?

The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 18.00, which implies 162.0% upside from the current price. This is not investment advice.

What is Aura Biosciences's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Aura Biosciences a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Aura Biosciences discussion 0 comments

Add a comment